Braxia Scientific Past Earnings Performance

Past criteria checks 0/6

Braxia Scientific has been growing earnings at an average annual rate of 28.4%, while the Healthcare industry saw earnings growing at 15% annually. Revenues have been growing at an average rate of 26.6% per year.

Key information

28.4%

Earnings growth rate

200.7%

EPS growth rate

Healthcare Industry Growth-6.7%
Revenue growth rate26.6%
Return on equityn/a
Net Margin-436.4%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Braxia Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CNSX:BRAX Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 232-1040
30 Sep 232-1150
30 Jun 232-1360
31 Mar 232-1370
31 Dec 222-1260
30 Sep 222-1370
30 Jun 221-1270
31 Mar 221-1270
31 Dec 211-871
30 Sep 211-761
30 Jun 211-752
31 Mar 211-8892

Quality Earnings: BRAX is currently unprofitable.

Growing Profit Margin: BRAX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BRAX is unprofitable, but has reduced losses over the past 5 years at a rate of 28.4% per year.

Accelerating Growth: Unable to compare BRAX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BRAX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.4%).


Return on Equity

High ROE: BRAX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/11/02 05:30
End of Day Share Price 2024/08/06 00:00
Earnings2023/12/31
Annual Earnings2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Braxia Scientific Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution